Skip to main content
Equibles
AFJK logo

AFJK · Aimei Health Technology Co., Ltd.

Track AFJK — free

Use AFJK with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AFJK

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$12.56 +0.23 (+1.87%) At close · Aug 21
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“management has determined that if we are unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of our IPO, the requirement that we cease all operations, redeem the public shares, and thereafter liquidate and dissolve, raises substantial doubt about the ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$39.77M
Shares
3.17M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$12.56 Open$12.38 Day$12.22–12.99 52W close$8.00–88.50 Avg vol 30d29K Short int2K · 0.1% float · 1.0d Short vol19% DataJan 2024–Aug 2026 Filing10-Q · Aug 13

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.1 · calm Equity put/call 0.51
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −61%
below
Price vs 50-day avg −35%
below
RSI (14) 35
neutral
MACD trend Positive
52-week position 6%
near low
Momentum
relative strength
Weak
1-month return +6%
trailing
6-month return −74%
trailing
YTD return −80%
this year
Relative strength −85%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $19 › 200d $32 — 200d above 50d
Institutional flow Distributing
-10% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.07% of float · ▼ -46.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
19 holders — near 2-yr low, contrarian setup
Squeeze score 26
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 1039%
annualized · 1-yr
Max drawdown −87%
past year
ATR 7.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−61% Bearish
Price vs 50-day avg
−35% Bearish
RSI (14)
35 Neutral
MACD trend
Positive Bullish
52-week position
6% Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $19 › 200d $32 — 200d above 50d
Institutional flow Distributing
-10% holders QoQ · +2 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.07% of float · ▼ -46.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
19 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
Range low $8 Now $13 · 6% Range high $89
vs 200-day avg -61% vs 50-day avg -35%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AFJK
Aimei Health Technology Co., Ltd.
this stock
$39.77M -80.4% — — 0.1%
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
CCXI
Churchill Capital Corp XI
 $811.55M — — — 3.8%
DMII
Drugs Made In America Acquisition II Corp.
 $645.92M +2.4% — — 0.2%
BCSS
Bain Capital GSS Investment Corp.
 $600.35M +2.0% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
19
% held
150.5%
Net QoQ
-330.3K sh
Top holder
HIGHBRIDGE CAPITAL MANAGE…
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
2.3K
Days to cover
1.0d
Change
-2.1K sh
View
Short Volume
Short vol %
19%
As of
Aug 21, 2026
Short Total
View
Fails to Deliver
FTD shares
19
Value
$228
As of
Jul 31, 2026
View
Off-Exchange
Off-exchange %
29.4%
Week of
Jul 13, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$1.1M
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 13, 2026
This year
15
View

Performance

5D 20D 120D MTD YTD
AFJK +3.0% +5.6% -73.8% +4.3% -80.4%
SPY -1.4% +3.6% +11.6% +2.5% +12.3%
vs SPY +4.3% +1.9% -85.4% +1.8% -92.7%
Key facts CIK 1979005 CUSIP G01341109 13F (30d) 20 filings 19 filers

Report a Problem

Category
Description
Email (optional, for follow-up)